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ABSTRACT 
Central venous catheterization is a common practice in the management of critically ill patients and is 
associated with various complications, such as Bloodstream Infections (BSI), which are major determinants 
of increased morbidity, mortality and healthcare expenses. Few studies have addressed factors that predict 
mortality in patients with this complication. The aim of this study was to investigate factors associated with 
mortality in patients with Central Venous Catheter (CVC)-related BSI in an intensive care unit of a tertiary 
care hospital in the Federal District, Brazil. This was a retrospective and observational study, in which all 
CVC-related BSI that occurred between January 2008 and December 2010 were reviewed. We obtained 
demographic, clinical, biochemical and microbiological data from medical records and investigated its 
association with mortality during ICU stay. There were 4,504 ICU admissions during the study period and 68 
were complicated by CVC-related BSI (4.09 per 1000 catheter-days), most due to gram-negative organisms 
(45.6%). Overall mortality was 59.7%. Death risk was significantly associated with mechanical ventilation 
(OR 27.8, 95% CI 3.28-250, p<0.001), the mean number of invasive devices other than the CVC (1.44 Vs 2.37 
in controls Vs cases, p<0.001) and increased serum levels of urea (mean value of 44.2 mg dL−1 in survivors vs. 
73.9 mg dL−1 in non-survivors, p = 0.001). Mortality was not associated with other clinical or biochemical 
features, neither with microbiological variables, although lethality was high among patients with gram-positive 
infections (77% Vs 58.33% for fungi and 54.83% for gram-negative). CVC-related BSI was associated with 
high absolute mortality, which was predicted by mechanical ventilation and a higher number of invasive 
devices other than the CVC. Knowledge of local factors predictive of mortality is critical for planning 
strategies to reduce death risk associated with this complication. 
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1. INTRODUCTION 
Central venous catheterization is a common practice 
with unquestionable benefits in the management of 
critically ill patients (Mcgee and Gould, 2003). 
However, it is also associated  with  potentially 
serious complications (McGee and Gould, 2003; 
Garnacho-Montero et al., 2008). One of the main 
complications is Central Venous Catheter (CVC)-
related Bloodstream Infection (BSI) (O’Grady et al., 
2011), which is a major determinant of increased 
morbidity, mortality, hospitalization length and health 
care expenses in the Intensive Care Unit (ICU)   
(Pittet et al., 1994; Garrouste-Orgeas et al., 2006). 





In the United States, 80,000 new cases of CVC-
related BSI are estimated to occur in ICUs each year 
(Mermel et al., 2009). In South America, there are fewer 
studies addressing this issue. In an Argentinian 5 year 
study involving 6 hospitals, it was reported that CVC-
related BSI complicated 2.92% of all ICU admissions, 
increased hospitalization length by 11.9 days and 
resulted in a 24.6% excess mortality (Rosenthal et al., 
2003). A Brazilian study carried out over a period of 
11 months in 7 public ICUs in the Federal District 
found a 6.4% frequency of overall BSI and a 1.5% 
frequency of CVC-related BSI. This complication 
increased 3.5 times the duration of hospitalization 
(Mesiano and Merchan-Haman, 2007). 
There are a number of interventions to attempt 
reducing the incidence of CVC-related BSI, mostly 
involving CVC insertion and care, such as barrier 
precautions, hand hygiene, skin antisepsis and careful 
CVC insertion site choice (O’Grady et al., 2002). 
Nevertheless, rationale and effective interventions to 
reduce CVC-related BSI rates and its associated mortality 
remain a major focus of research (Vincent et al., 2009) 
and identifying the factors that predict the occurrence of 
these infections and its associated mortality might 
contribute to improvement of these interventions. The aim 
of this study was to investigate factors associated with 
mortality in patients with central venous catheter CVC-
related BSI in an intensive care unit of a tertiary care 
hospital in the Federal District, Brazil. 
2. MATERIALS AND METHODS 
2.1. Study Design 
This study was carried out in a 40-bed medical-
surgical ICU of a tertiary care hospital in Brasília, 
(Federal District, Brazil). All occurrences of CVC-
related BSI from January 2008 to December 2010 were 
prospectively investigated. The diagnosis of CVC-related 
BSI was defined according to the local protocol, which 
follows the recommendations from the Centers for 
Disease Control and Prevention, CDC (O’Grady et al., 
2002; Mermel et al., 2009). 
Patients aged over 18 years were included in the 
study and only the first episode of CVC-related BSI was 
considered if there was more than one episode of 
infection per patient during ICU stay. Exclusion criteria 
were CVC insertion prior to ICU admission, pregnancy 
and patients who were transferred to another ICU.  
The following data were collected: age, gender, 
admission APACHE II score, reason for ICU admission, 
comorbidities, need for mechanical ventilation and renal 
replacement therapy, need for glucocorticoid or insulin 
therapy during ICU stay, need for other invasive devices, 
length of ICU stay and time period between admission and 
CVC-related BSI diagnosis. Biochemical (serum urea, 
creatinine, glucose and lactate levels), CVC-related 
(insertion site) and microbiological (microbiological 
isolate causing the infection: gram-positive, gram-negative 
or fungi) data were collected from medical records.  
The study was approved by the local ethics 
committee, which required no written informed consent 
because it was an observational and retrospective study 
based on routinely obtained information in the ICU.  
2.2. Statistical Analysis 
Continuous variables were reported as the appropriate 
measures of central tendency and categorical variables, 
as percentages. CVC-related BSI rate was reported as 
incidence density (number of case per 1000 catheter-
days). The patient status (survivor or non-survivor) at the 
end of ICU stay was considered as the outcome variable. 
The association of the outcome variable with the 
categorical variables analyzed was expressed as the Odds 
Ratio (OR) with 95% Confidence Intervals (95% CI). 
The frequency of these variables in survivors and non-
survivors groups was compared using simple logistic 
regression. For continuous variables showing normal 
distribution, mean values were compared using t-Student 
test. For those not showing normal distribution, median 
values were compared using Mann-Whitney and 
Kruskal-Wallis tests. Statistical significance was set at p-
value <0.05. Statistical analyses were done using the 
17th version of the Statistical Package for the Social 
Sciences (Chicago, IL, US) and R Statistics softwares. 
3. RESULTS 
3.1. Study Population 
A total of 4,504 patients were admitted to the ICU 
during the study period and CVC-related BSI was 
diagnosed in 68 patients (1.53%). The corresponding 
incidence density of this infection was 4.09 per 1000 
catheter-days. All cases were included in the study.  
Patients with CVC-related BSI had a mean age of 
72.20±17.0 years and 54.4% were male. Mean 
APACHE II score on admission was 16.4±5.6 and the 
mean duration of ICU stay was 91.22±77.40 days. The 
most common reason for ICU admission was medical 
conditions associated with infection (50.0%) and the 
most frequent comorbidity was diabetes (27.9%), as 
shown in Table 1.  
The most commonly needed invasive procedure was 
mechanical ventilation (82.1%) and 22.4% of patients 
needed hemodialysis as renal replacement therapy.  





Table 1. Demographic and clinical features of patients with CVC-related BSI 
 Total study period (2008-2010) N = 68 
Demographic data 
Age (mean ± SD) 72.20±17.0 
Male gender (%) 54.4 
Clinical data 
APACHE II at admission (mean ± SD) 16.4±5.6 
Length of ICU stay in days (mean ± SD) 91.22±77.40 
ICU admission reason 
Clinical without infection (%) 16.6 
Clinical with infection (%) 50.0 
Surgical without infection (%) 22.1 
Surgical with infection (%) 11.8 
Comorbidities 
Diabetes mellitus (%) 27.9 
Oncologic disease (%) 10.3 
Chronic renal disease (%) 10.3 
Need for mechanical ventilation (%) 82.1 
Need for dialysis (%) 22.4 
Mean number of invasive devices other than the CVC 2.0 
Time period between ICU admission and diagnosis of  38.2±28.8 
CVC-related BSI (mean ± SD) 
Insulin therapy (%) 94.0 
Glucocorticoid therapy (%) 31.3 
CVC insertion site 
Subclavian vein (%) 91.0 
Internal jugular vein (%) 7.5 
Femoral vein (%) 1.5 
Outcome 
Mortality (%) 59.7 
SD: Standard Deviation; APACHE II: Acute Physiology and Chronic Health disease Classification System II; CVC: Central Venous 
Catheter; BSI: Bloodstream Infection; ICU: Intensive Care Unit 
 
Table 2. Demographic and clinical features and death risk among patients with CVC-related BSI 
 Survivors N = 27 Non-survivors N = 41 OR (95% IC) p-value 
Mean age ± SD 69.3±15.0 74.1±18.3  0.080 
Male gender 13 (48.14%) 24 (58.3%) 1.52 (0.57-4.04) 0.277 
Apache II at admission (mean ± SD) 15.7 ± 4.9 16.9±6.0  0.700 
ICU admission reason 
Clinical without infection 4 (14.8%) 7 (17.1%) 0.84 (0.22-3.2) 0.542 
Clinical with infection 11 (40.7%) 23 (56.1%) 1.86 (0.69-4.9) 0.161 
Surgical without infection 7 (25.9%) 8 (19.5%) 0.69 (0.22-2.2) 0.369 
Surgical with infection 5 (18.5%) 3 (7.3%) 2.9 (0.63-13.2) 0.154 
Comorbidities 
Oncologic disease 1 (3.7%) 6 (14.6%) 4.46 (0.50-40.0) 0.148 
Diabetes mellitus 7 (25.9%) 12 (29.3%) 1.18 (0.4-3.52) 0.494 
Chronic renal disease 4 (14.8%) 3 (7.3%) 0.45 (0.09-2.2) 0.275 
Need for mechanical ventilation 16 (59.3%) 40 (97.6%) 27.8 (3.28-250) < 0,001 
Need for dialysis 6 (22.2%) 9 (22%) 1.02 (0.31-3.3) 0.603 
Glucocorticoid therapy 8 (29.6%) 13 (31.7%) 1.10 (0.38-3.2) 0.537 
Insulin therapy 26 (96.3%) 38 (92.7%) 0.49 (0.05-4.9) 0.478 
CVC insertion site 
Subclavian vein 25 (92.6%) 37 (90.2%) 1.35 (0.23-7.9) 0.551 
Internal jugular vein 1 (3.7%) 4 (9.8%) 2.8 (0.29-26.3) 0.334 
Femoral vein 1 (3,7%) A0 - - 
Mean number of invasive 1.44±1.0 2.37±0.8  < 0.001 
devices other than the CVC 
Mean length of ICU stay in days ± SD 87.6±6.8 93.6 ±78.7  0.878 
CVC: Central Venous Catheter; ICU: Intensive Care Unit; SD: Standard Deviation; OR: Odds Ratio, 95% IC: 95% confidence interval 





Table 3. Biochemical features and death risk among patients with CVC-related BSI 
 Survivors N = 27 Non-survivors N = 41 p-value 
Urea, mg/dL (mean ± SD) 44.2±42.1 73.9±45.0 0.001 
Creatinine, mg/dL (mean ± SD) 1.2±1.3 1.4±1.5 0.411 
Glucose, mg/dL (mean ± SD) 123±34.6 148.2±70.2 0.125 
Lactate, mmol/L (mean ± SD) 1.2±0.97 2.1±2.7 0.093 
SD: Standard Deviation 
 
Table 4. Microbiological diagnosis and death risk among patients with CVC-related BSI 
 N (%) Mortality N (%) Lethality (%) OR (95%IC) p-value 
Gram-positive 13 (19.1) 10 (14.7) 77.00 2.6 (0.64-10.4) 0.147 
Gram-negative 31 (45.6) 17 (25) 54.83 0.65 (0.23-1.7) 0.277 
Fungi 24 (35.3) 14 (20.58) 58.33 0.88 (0.32-2.4) 0.504 
OR: Odds Ratio, 95% IC: 95% confidence interval 
 
The mean number of invasive devices other than the 
CVC was 2.0 and the mean time period between ICU 
admission and diagnosis of CVC-related BSI was 
38.2±28.8 days. The need for insulin (94%) and 
glucocorticoid (31.3%) therapy was frequent. The most 
common CVC insertion site was the subclavian vein 
(Table 1). Biochemical data collected within a 5 day 
period of CVC-related BSI diagnosis showed mean 
serum levels of urea of 62.1±46.5 mg dL−1 (reference 
range, RR 10-46), creatinine of 1.3±1.4 mg dL−1 (RR 
0.6-1.1), glucose of 138.2±59.7 mg dL−1 and lactate of 
1.7±2.3 mmol/L (RR 0.4-2.0). Most cases of CVC-
related BSI were due to gram-negative organisms 
(45.6%), followed by fungi (35.3%) and gram-positive 
(19.1%) organisms. There were no cases of 
polymicrobial CVC-related BSI. 
3.2. Factors Associated with Mortality among 
Patients with CVC-Related BSI 
In    the   study    period,   there   were   41   deaths 
among  patients   with  CVC-related  BSI, 
corresponding    to     a    mortality       of         59.7%. 
There was a significant association between death risk 
and the need for mechanical ventilation (OR 27.8, IC 
95% 3.28-250.00, p<0.001) and the mean number of 
invasive devices other than the CVC (1.44 Vs 2.37 in the 
survivors vs. non-survivors group, p<0.000). There was a 
trend towards association between mortality and the 
presence of oncologic disease (OR 4.46), although not 
statistically significant (IC 95% 0.50-40.0, p = 0.148). 
There was no association between death risk and the 
other demographic and clinical variables analyzed 
such as admission APACHE II score, diabetes, 
chronic renal disease, the need for hemodialysis and 
the mean length of ICU (Table 2). 
Interestingly, serum levels of urea, but not those of 
creatinine, were significantly associated with death risk 
(mean urea serum levels of 44.2 mg dL−1 in survivors 
Vs 73.9 mg dL−1 in non-survivors, p = 0.001). Other 
biochemical variables were not associated with 
mortality, as shown in Table 3. Mortality was higher 
(25.0%) in patients with CVC-related BSI due to 
gram-negative organisms, although patients with 
gram-positive infections showed the highest lethality 
(77%). However, no association was found between 
microbiological diagnosis and death risk in patients 
with CVC-related BSI (Table 4). 
4. DISCUSSION 
Nosocomial BSIs are primarily associated with 
intravascular devices, such as CVCs and represent a 
major determinant of morbidity and mortality among 
critically ill patients (Laupland et al., 2002; Vincent, 
2003; Garrouste-Orgeas et al., 2006; Vincent et al., 
2009). We studied 4,504 ICU admissions over a period 
of three years; 1.53% of them were complicated by 
CVC-related BSI and the correspondent incidence 
density was 4.09 per 1000 catheter-days. Patients with 
CVC-related BSI in our study were old (mean age of 
72.20 years) and there was a slight male 
preponderance (54.4%). We found a high overall 
mortality in patients with this complication (59.7%). 
There is a large variation in the incidence and 
mortality rates of CVC-related BSI in the ICU setting 
worldwide. These reasons for these discrepancies are not 
completely defined, but are believed to reflect at least in 
part the diversity of local clinical practices, distinct 
patient characteristics and the different designs of 
epidemiological studies from which these data are 
derived (Tacconelli et al., 2009; O’Grady et al., 2011). 
Data from the SCOPE (Surveillance and Control of 
Pathogens of Epidemiologic Importance) study, 





comprising 49 hospitals in the United States, indicated 
an incidence of 60 cases of nosocomial BSI per 10,000 
hospital admissions, 50.5% of which occurred in the 
ICU and a crude mortality of all BSI of 27% 
(Wisplinghoff et al., 2004). In France, the National 
Nosocomial Infection Survey estimated an incidence 
rate of CVC-related BSI of 1.23 per 1000 catheters-
days (Tacconelli et al., 2009) and another European 
study reported a 43.9% mortality of BSI in the ICU 
(Pratikaki et al., 2009). In South America, an 
Argentinian study found a 2.92% incidence of CVC-
related BSI in the ICU, with a crude mortality of 52.4% 
(Rosenthal et al., 2003). A Brazilian study also 
conducted in the ICU setting reported a 1.5% frequency 
of CVC-related BSI with a 40% overall mortality 
(Mesiano and Merchan-Haman, 2007). We found an 
incidence of CVC-related BSI similar to the latter study, 
although mortality in our study population was 
considerably higher. This finding might be attributable to 
some of the patient’s features, which are predictive of 
increased overall mortality, such as advanced age, illness 
severity on ICU admission as indicated by a high 
APACHE II score (mean of 16.4), serious underlying 
diseases (malignancy, diabetes and chronic renal disease) 
and the common need for other invasive procedures 
(Garnacho-Montero et al., 2008; Stoeckle et al., 2008;  
Son et al., 2010). 
In addition, in this study death risk was associated 
with the need for mechanical ventilation and with a 
higher mean number of invasive devices other than the 
CVC. It was also associated with urea but not creatinine 
serum levels and this may reflect the advanced age of our 
study population. No significant differences were found 
for other variables analyzed. In other studies, several 
factors have been described as predictive of mortality in 
patients with CVC-related BSI, such as adult 
respiratory distress syndrome, shock, multiorgan 
failure, mechanical ventilation, chronic hepatic 
failure, acute renal failure and APACHE II score 
greater than 14 (Rello et al., 1994; Valles et al., 1997; 
Garrouste-Orgeas et al., 2006). Unlike these studies, 
we could not find an association of mortality with 
admission APACHE II score. It is also noteworthy 
that factors associated with mortality risk, including 
those found in our study, may all be viewed as 
surrogate markers of illness severity, rather than 
specific etiologic factors for mortality. 
We found a predominance of CVC-related BSI 
infections due to gram-negative organisms over fungi 
and gram-positive. Although this is in disagreement with 
the more recent reports indicating an increased incidence 
of gram-positive organisms in patients with BSI in the 
ICU setting (Wisplinghoff et al., 2004), it may be 
explained by local factors and also by the increased age 
of our study population and the severity of their clinical 
status, which have been found to be associated with 
increased risk for gram-negative infections (Waterer and 
Wunderink, 2001; Kohlenberg et al., 2008; Vincent et al., 
2009). Mortality was higher among patients with CVC-
related BSI due gram-negative bacteria (25%), in 
agreement with data from the Extended Prevalence of 
Infection in Intensive Care (EPIC II) study, which 
comprised 75 countries and found that mortality was 
higher among ICU patients with infections due to gram-
negative organisms (Vincent et al., 2009). Lethality, 
however, was higher among patients with infections due 
to gram-positive organisms (77%) in our study. 
This study has some limitations, including the 
relatively small absolute number of CVC-related BSI 
occurrences and the high absolute mortality in patients with 
this complication, which may have precluded us from 
finding differences between survivors and non-survivors. 
Moreover, our study did not include a control group of 
patients submitted to CVC insertion but without CVC-
related BSI and it was limited to only one ICU facility. 
5. CONCLUSION 
We found a high mortality in patients with CVC-
related BSI, which was associated with need for 
mechanical ventilation, with a higher mean number of 
invasive devices other than the CVC and with a higher 
serum level of urea. This suggests that in addition to 
rigorous infection control measures to reduce the incidence 
of this complication in the ICU setting, it is important to 
develop strategies to improve patient outcome when CVC-
related BSI infection occurs and these strategies should 
focus specially on severely ill patients. 
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